The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.34 | Sales 2021 | 12.35 16.99 | Capitalization | 22.37M 30.78M |
---|---|---|---|---|---|
Net income 2020 | -126M -173M | Net income 2021 | -85M -117M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 40.18M | Net Debt 2021 | 17.1M 23.53M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+41.81% | 6.2B | |
-22.93% | 4.1B | |
+9.84% | 3.41B | |
-18.80% | 2.83B | |
-10.82% | 2.29B | |
+48.92% | 1.93B | |
-7.03% | 1.52B | |
+49.25% | 1.51B | |
-15.60% | 1.49B |